{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:59:43Z","timestamp":1794891583044,"version":"4.9.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Among patients with severe polycystic liver disease (PLD) (height-adjusted total liver volume of &lt;1800 ml\/m),\n                            <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                            variants were found in 34%.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Three patients with\n                            <jats:italic toggle=\"yes\">PKD1<\/jats:italic>\n                            or\n                            <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                            variants are reported with severe PLD but normal-sized kidneys (hTKV of &lt; 250 ml\/m).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic liver disease (PLD) is present in most patients with autosomal dominant polycystic kidney disease (ADPKD). PLD can alternatively be found with few, if any, kidney cysts as a diagnosis of isolated PLD (autosomal dominant PLD [ADPLD]). Several genes are identified as causative for this spectrum of phenotypes; however, the relative incidence of genetic etiologies among patients with severe PLD is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with ADPKD or ADPLD having severe PLD defined as height-adjusted total liver volume (hTLV) &gt;1800 ml\/m were recruited. Subsequent clinical care was followed. Genetic analysis was performed using whole exome sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We enrolled and sequenced 49 patients (38 women, 11 men). Pathogenic or suspected pathogenic variants in polycystic disease genes were found in 44 of 49 patients (90%). The disease gene was\n                      <jats:italic toggle=\"yes\">PKD1<\/jats:italic>\n                      in 20 of 44 patients (45%),\n                      <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                      in 15 of 44 patients (34%),\n                      <jats:italic toggle=\"yes\">PRKCSH<\/jats:italic>\n                      in 5 of 44 patients (11%),\n                      <jats:italic toggle=\"yes\">GANAB<\/jats:italic>\n                      in 2 of 44 patients (5%),\n                      <jats:italic toggle=\"yes\">SEC63<\/jats:italic>\n                      in 1 of 44 patients (2%), and\n                      <jats:italic toggle=\"yes\">ALG8<\/jats:italic>\n                      in 1 of 44 patients (2%). The median hTLV was no different between genetically defined ADPKD and ADPLD groups (4431 [range, 1817\u20139148] versus 3437 [range, 1860\u20138211]) ml,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.77), whereas height-adjusted kidney volume was larger as expected in ADPKD than in ADPLD (607 [range, 190\u20132842] versus 179 [range, 138\u2013234] ml\/m,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Of the clinically defined ADPKD patients, 20 of 38 patients (53%) were\n                      <jats:italic toggle=\"yes\">PKD1<\/jats:italic>\n                      , 15 of 38 (39%) were\n                      <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                      , and 3 (8%) remained genetically unsolved. Among patients with a pathogenic\n                      <jats:italic toggle=\"yes\">PKD1<\/jats:italic>\n                      or\n                      <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                      variant, we found three patients with a liver-dominant ADPKD (severe PLD with height-adjusted total kidney volume &lt;250 ml\/m).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      ADPLD-related genes represent 20% of patients with severe PLD in our cohort. Of those enrolled with ADPKD, we observed a higher frequency of\n                      <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                      carriers than in any previously reported ADPKD cohorts. Although there was no significant difference in the hTLV between patients with\n                      <jats:italic toggle=\"yes\">PKD1<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                      in this cohort, our data suggest that enrollment on the basis of severe PLD may enrich for patients with\n                      <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000000000000461","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:01:15Z","timestamp":1714521675000},"page":"1106-1115","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Genetic Analysis of Severe Polycystic Liver Disease in Japan"],"prefix":"10.34067","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4187-1067","authenticated-orcid":false,"given":"Hiroki","family":"Mizuno","sequence":"first","affiliation":[{"name":"Nephrology Center Toranomon Hospital Kajigaya, Kawasaki, Japan"},{"name":"Nephrology Center Toranomon Hospital, Tokyo, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-1507","authenticated-orcid":false,"given":"Whitney","family":"Besse","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7326-4988","authenticated-orcid":false,"given":"Akinari","family":"Sekine","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital, Tokyo, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2935-0430","authenticated-orcid":false,"given":"Kelly T.","family":"Long","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigekazu","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital Kajigaya, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1494-3291","authenticated-orcid":false,"given":"Yuki","family":"Oba","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital Kajigaya, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3264-9691","authenticated-orcid":false,"given":"Masayuki","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital Kajigaya, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-2512","authenticated-orcid":false,"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital Kajigaya, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-4094","authenticated-orcid":false,"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital Kajigaya, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital Kajigaya, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5062-4629","authenticated-orcid":false,"given":"Stefan","family":"Somlo","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Department of Genetics, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-101X","authenticated-orcid":false,"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital, Tokyo, Japan"},{"name":"Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"issue":"1","key":"B1-20250823","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B2-20250823","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the consortium for radiologic imaging studies of polycystic kidney disease cohort","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B3-20250823","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int."},{"issue":"1","key":"B4-20250823","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1478-3231.2010.02247.x","article-title":"Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases","volume":"31","author":"Van Keimpema","year":"2011","journal-title":"Liver Int."},{"issue":"6","key":"B5-20250823","doi-asserted-by":"crossref","first-page":"100166","DOI":"10.1016\/j.jhepr.2020.100166","article-title":"Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county","volume":"2","author":"Suwabe","year":"2020","journal-title":"JHEP Rep."},{"issue":"10","key":"B6-20250823","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B7-20250823","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.ackd.2009.12.005","article-title":"Isolated polycystic liver disease","volume":"17","author":"Qian","year":"2010","journal-title":"Adv Chronic Kidney Dis."},{"key":"B8-20250823","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu Rev Med."},{"issue":"7","key":"B9-20250823","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","article-title":"Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B10-20250823","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1086\/368295","article-title":"Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease","volume":"72","author":"Li","year":"2003","journal-title":"Am J Hum Genet."},{"issue":"6","key":"B11-20250823","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","article-title":"Mutations in SEC63 cause autosomal dominant polycystic liver disease","volume":"36","author":"Davila","year":"2004","journal-title":"Nat Genet."},{"issue":"9","key":"B12-20250823","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI96729","article-title":"Isolated polycystic liver disease genes define effectors of polycystin-1 function","volume":"127","author":"Besse","year":"2017","journal-title":"J Clin Invest."},{"issue":"11","key":"B13-20250823","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2019030298","article-title":"ALG9 mutation carriers develop kidney and liver cysts","volume":"30","author":"Besse","year":"2019","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B14-20250823","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet."},{"key":"B15-20250823","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddm141","article-title":"Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway","volume":"16","author":"Garcia-Gonzalez","year":"2007","journal-title":"Hum Mol Genet."},{"issue":"7","key":"B16-20250823","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ng.860","article-title":"A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation","volume":"43","author":"Fedeles","year":"2011","journal-title":"Nat Genet."},{"issue":"2","key":"B17-20250823","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1478-3231.2007.01595.x","article-title":"Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease","volume":"28","author":"Hoevenaren","year":"2008","journal-title":"Liver Int."},{"issue":"3","key":"B18-20250823","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.08660621","article-title":"Volume progression and imaging classification of polycystic liver in early autosomal dominant polycystic kidney disease","volume":"17","author":"Bae","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B19-20250823","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jamcollsurg.2015.12.051","article-title":"Outcomes and durability of hepatic reduction after combined partial hepatectomy and cyst fenestration for massive polycystic liver disease","volume":"223","author":"Chebib","year":"2016","journal-title":"J Am Coll Surg."},{"issue":"4","key":"B20-20250823","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/01.tp.0000231712.75645.7a","article-title":"Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome","volume":"82","author":"Ueno","year":"2006","journal-title":"Transplantation."},{"issue":"1","key":"B21-20250823","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/SLA.0b013e3181ad83dc","article-title":"Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation","volume":"250","author":"Schnelldorfer","year":"2009","journal-title":"Ann Surg."},{"issue":"3","key":"B22-20250823","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jlts.2001.22178","article-title":"Liver transplantation for polycystic liver disease","volume":"7","author":"Pirenne","year":"2001","journal-title":"Liver Transpl."},{"issue":"6","key":"B23-20250823","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"B24-20250823","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2015050583","article-title":"For the HALT PKD and CRISP investigators: predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease","volume":"27","author":"Heyer","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B25-20250823","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/ndt\/gfw008","article-title":"Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease","volume":"31","author":"Chebib","year":"2016","journal-title":"Nephrol Dial Transplant."},{"issue":"12","key":"B26-20250823","doi-asserted-by":"crossref","first-page":"e0144526","DOI":"10.1371\/journal.pone.0144526","article-title":"Clinical correlates of mass effect in autosomal dominant polycystic kidney disease","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One."},{"issue":"7809","key":"B27-20250823","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature."},{"issue":"5","key":"B29-20250823","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"issue":"3","key":"B30-20250823","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet."},{"issue":"8","key":"B31-20250823","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","article-title":"Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies","volume":"24","author":"Dong","year":"2015","journal-title":"Hum Mol Genet."},{"issue":"4","key":"B32-20250823","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet."},{"issue":"6","key":"B33-20250823","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/j.ajkd.2014.01.422","article-title":"Intravascular embolization therapy in patients with enlarged polycystic liver","volume":"63","author":"Hoshino","year":"2014","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"B34-20250823","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B35-20250823","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.1840210515","article-title":"Calculation of child and adult standard liver volume for liver transplantation","volume":"21","author":"Urata","year":"1995","journal-title":"Hepatology."},{"issue":"15","key":"B36-20250823","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","article-title":"1000 genomes Project analysis group: the variant call format and VCFtools","volume":"27","author":"Danecek","year":"2011","journal-title":"Bioinformatics."},{"issue":"1","key":"B37-20250823","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41525-022-00309-w","article-title":"PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan","volume":"7","author":"Yu","year":"2022","journal-title":"NPJ Genom Med."},{"issue":"47","key":"B38-20250823","doi-asserted-by":"crossref","first-page":"18688","DOI":"10.1073\/pnas.0708217104","article-title":"Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure","volume":"104","author":"Yu","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"B39-20250823","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1172\/JCI67273","article-title":"Altered trafficking and stability of polycystins underlie polycystic kidney disease","volume":"124","author":"Cai","year":"2014","journal-title":"J Clin Invest."},{"issue":"1","key":"B40-20250823","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/cells5010003","article-title":"The role of G-protein-coupled receptor proteolysis site cleavage of polycystin-1 in renal physiology and polycystic kidney disease","volume":"5","author":"Trudel","year":"2016","journal-title":"Cells."},{"issue":"1","key":"B44-20250823","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"20","key":"B45-20250823","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med."},{"issue":"8","key":"B46-20250823","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.2009020162","article-title":"Family history of renal disease severity predicts the mutated gene in ADPKD","volume":"20","author":"Barua","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"24","key":"B47-20250823","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","author":"Torres","year":"2014","journal-title":"N Engl J Med."},{"issue":"3","key":"B48-20250823","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B49-20250823","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/gfx188","article-title":"Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial","volume":"33","author":"Cornec-Le Gall","year":"2018","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"B50-20250823","doi-asserted-by":"crossref","first-page":"432","DOI":"10.23876\/j.krcp.21.261","article-title":"Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study","volume":"41","author":"Park","year":"2022","journal-title":"Kidney Res Clin Pract."},{"issue":"2","key":"B51-20250823","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ekir.2021.11.034","article-title":"Long-term outcomes of longitudinal efficacy study with tolvaptan in ADPKD","volume":"7","author":"Higashihara","year":"2022","journal-title":"Kidney Int Rep."},{"issue":"3","key":"B52-20250823","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ekir.2021.12.012","article-title":"Germline mutations for kidney volume in ADPKD","volume":"7","author":"Kataoka","year":"2022","journal-title":"Kidney Int Rep."},{"issue":"7","key":"B53-20250823","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/biom13071020","article-title":"PKD1 mutation is a biomarker for autosomal dominant polycystic kidney disease","volume":"13","author":"Kimura","year":"2023","journal-title":"Biomolecules."},{"issue":"5","key":"B54-20250823","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/j.gastro.2023.12.007","article-title":"Sex, genotype, and liver volume progression as risk of hospitalization determinants in autosomal dominant polycystic liver disease","volume":"166","author":"Sch\u00f6nauer","year":"2024","journal-title":"Gastroenterology."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000000000461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:58:57Z","timestamp":1786478337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000000000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000000000461","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"assertion":[{"value":"2023-10-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}